...
| Excerpt |
|---|
 This collection contains data from the Clinical Trial NCT02066181 "Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis". , Principal Investigator: Mrinal M. Gounder (Alliance for Clinical Trials in Oncology). It was sponsored by NCI's Alliance for Clinical Trials in Oncology under study number A091105. This randomized phase III trial compares the effects, good and/or bad, of sorafenib tosylate in treating patients with desmoid tumors or aggressive fibromatosis. Sorafenib tosylate may stop the growth of tumor cells by blocking some of the proteins needed for cell growth. [Funding Source - FDA OOPD]. Select patient-level clinical data from this trial is available via the following link: https://nctn-data-archive.nci.nih.gov/node/1266. |
...